Fewer students dropping out of university, figures show
The rate of students dropping out from UK universities has fallen slightly, figures show.
University of Oxford
Three months between Oxford Covid-19 vaccine doses boosts effectiveness – study
The UK policy of leaving 12 weeks between doses of the Oxford/AstraZeneca coronavirus vaccine boosts the jab’s effectiveness, a new study has found.
Dexamethasone finding may have already saved 650,000 lives – study
Using dexamethasone to treat Covid-19 patients could have saved 650,000 lives around the world, a study suggests.
NHS Covid-19 app has asked 1.7 million to isolate since September launch – DHSC
More than 1.7 million people have been asked to isolate via the NHS Covid-19 app since it launched in September, according to the Department of Health and Social Care (DHSC).
Proportion of black and minority ethnic students at Oxford reaches record high
The University of Oxford accepted record numbers of British students from ethnic minority backgrounds last year.
Decision to reject vaccine ‘is between AstraZeneca and Swiss authorities’
Switzerland’s decision not to authorise use of the University of Oxford’s Covid-19 jab is between the country’s medical regulator and AstraZeneca, a leading vaccine expert has said.
Covid-19 positivity rate drops 50% in healthcare workers after first jab – study
The rate of healthcare workers testing positive for coronavirus dropped by 50% 12 days after they received the first Covid-19 vaccine dose, new data suggests.
UK ‘past the peak’ in cases, hospital admissions and deaths
Coronavirus cases, hospital admissions and deaths will continue to fall as the UK has passed the peak in the current wave of the pandemic, England’s chief medical officer has said.
PM warns Covid-19 infections are ‘alarmingly high’ as he hails vaccine milestone
Boris Johnson has warned that coronavirus infections remain “alarmingly high” and the NHS is still under “huge pressure”, despite promising vaccination data.
Vaccines against Covid variants will be ready by autumn – AstraZeneca
Vaccines against new coronavirus variants should be ready by October, the team behind the Oxford University/AstraZeneca jab has said.
Could the Oxford/AstraZeneca vaccine change the course of the Covid-19 pandemic?
The University of Oxford has released new data on its coronavirus vaccine which suggests the jab may reduce transmission by 67%.
Oxford transmission data ‘will help us out of pandemic’, Hancock says
Data from Oxford University showing its vaccine cuts transmission “will help us all to get out of this pandemic”, Matt Hancock has said, as hopes were raised over the lifting of lockdown.
Oxford vaccine reduces transmission of coronavirus, study suggests
A single dose of the Oxford vaccine may reduce transmission of coronavirus by two thirds, according to a new study which provides a major boost to the UK’s recommendation that the second jab should be delayed for up to 12 weeks.
Oxford jab protects 12 weeks after single dose and may cut transmission – study
The University of Oxford’s coronavirus vaccine offers protection of 76% up to 12 weeks after a single dose and may reduce transmission by 67%, according to a new study.
Johnson & Johnson Covid-19 vaccine: Who will get it, when and how?
The world’s first single-shot Covid vaccine seems to offer some protection against the virus, but not as well as some two-shot rivals, trial results have shown.
Mutant coronavirus strains being monitored for ‘vaccine evasion’
Health officials are monitoring mutant coronavirus variants to see which ones could cause “vaccine evasion”, a senior Government adviser has said.
More deadly and transmissible coronavirus variant is a ‘turn for the worse’
Indications the mutant coronavirus variant which emerged in the south of England may be more deadly and be more transmissible are a “serious turn for the worse”, a leading scientist has said.
Bowel cancer diagnoses fell during first lockdown in England, study suggests
New research suggests that since the first coronavirus lockdown, the number of people diagnosed with bowel cancer in England has fallen sharply, with a deficit persisting up to October 2020.
Private firms pocketing millions from disinformation-for-hire, report says
Private companies are increasingly being hired by governments and political parties to manipulate public opinion through social media, according to new research.
No limit to benefits of exercise in reducing cardiovascular disease risk – study
There is no limit to the benefits of exercise in reducing the risk of cardiovascular disease, according to a new study.
Targeting arterial stiffening ‘may provide benefits for later brain health’
Targeting arterial stiffening earlier in a person’s life could provide benefits for brain health in older age – and may help to delay the onset of dementia, researchers suggest.
Who will get the Oxford Covid-19 vaccine and how?
The first doses of the Covid-19 vaccine developed by the University of Oxford and AstraZeneca have been administered in the UK.
What do we know about the Oxford Covid-19 vaccine?
Every adult in Britain will be able to get a coronavirus vaccine, the Health Secretary has confirmed.
Oxford Covid-19 vaccine: Who will get it, when and how?
The Covid-19 vaccine developed by the University of Oxford and AstraZeneca has been approved for use in the UK.
Oxford’s Covid-19 vaccine is safe and effective, further data shows
The University of Oxford’s coronavirus vaccine induces an immune response and is safe, according to more data published by researchers.
Oxford Covid-19 vaccine stimulates broad antibody and T cell functions – study
The University of Oxford’s coronavirus vaccine stimulates broad antibody and T cell responses, published trial results show.
Russia’s coronavirus vaccine has efficacy of 91.4%, trial results suggest
Russia’s coronavirus vaccine is up to 91.4% effective at stopping people developing Covid-19 symptoms, according to its developers.
Oxford Covid-19 vaccine ‘could be licensed for use in the elderly’
The University of Oxford’s Covid-19 vaccine could be licenced for use in the elderly, the lead researcher of the trial has said.
What is the state of play with Covid-19 vaccines in the UK?
As the NHS started rolling out the Pfizer/BioNTech vaccine, peer-reviewed results of phase three of the University of Oxford vaccine were published.
Oxford Covid-19 vaccine has good safety record and efficacy – study
Oxford University’s Covid-19 vaccine “has a good safety record and efficacy” and could help control the pandemic, a scientist leading the study has said, as phase three data was published.